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SCIENTIFIC ACHIEVEMENTAWARD2011 Scientific Achievement Award recipient: Marc R. de Leval, MDThomas L. Spray, MDThe American Association for Thoracic Surgery (AATS)
presented the Scientific Achievement Award, one of the
most prestigious honors that can be given by the AATS,
to Dr Marc R. de Leval of London, England, during the
91st Annual Meeting in Philadelphia, Pennsylvania. Dr de
Leval is an extraordinarily accomplished congenital cardio-
vascular surgeon, respected researcher, scholar, teacher and
mentor, and an extraordinarily thoughtful individual.
Marc Roger de Leval was born in a small village in Bel-
gium to a family of general practitioners. He undertook his
medical school training at Liege University in Belgium and
completed a residency in internal medicine and 3 years of
general surgery training at the same institution. At that
point, he decided to become a heart surgeon and, because
there was no program for training in Liege, he applied for
a fellowship at the Pacific Medical Center in San Francisco
under Frank Gerbode. After 2 years in San Francisco, he
was appointed as senior surgical registrar at the Great Or-
mond Street Hospital for Sick Children in London under
David Waterston and Jaroslav Stark.
Professor de Leval was awarded the Evarts A. Graham
Memorial Traveling Fellowship of the AATS and spent
a year (1973–1974) at the Mayo Clinic under Robert Wal-
lace, Dwight McGoon, and Gordon Danielson and then re-
turned to Great Ormond Street Hospital where he was
appointed to the staff in 1974. He continued his career at
the Great Ormond Street Hospital for Sick Children until re-
tirement from the National Health Service in 2006.
Dr de Leval has had an extraordinarily productive career
of contributions to the field of cardiovascular surgery and to
congenital cardiac surgery. As a fellow in California, he par-
ticipated in the development of the use of the activated clot-
ting time for heparin management for patients on
cardiopulmonary bypass. This technique has now become
standard in bypass management and was a major step
forward in safe conduction of cardiopulmonary bypass
and long-term support using extracorporeal membrane
oxygenation.
Dr de Leval popularized the use of a prosthetic graft from
the subclavian artery to the pulmonary artery (the modified
Blalock-Taussig or Great Ormond Street shunt) as a way of
permitting growth of the natural blood vessel to regulateFrom the Division of Cardiology, Children’s Hospital of Philadelphia, Philadelphia,
Pa.
Address for reprints: Ryan Walther, American Association for Thoracic Surgery, 500
Cummings Center, Suite 4550, Beverly, MA 01915 (E-mail: rwalther@aats.org).
J Thorac Cardiovasc Surg 2012;143:767-8
0022-5223/$36.00
Copyright  2012 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2012.01.057
The Journal of Thoracic and Caflow in a larger prosthetic graft to improve palliation of chil-
dren with cyanotic congenital heart disease. The modified
Blalock-Taussig shunt is now the standard approach to aor-
topulmonary shunting in a wide variety of heart lesions and
has supplanted other shunts for its technical simplicity and
reproducibility.
One of the major disadvantages of surgical repair in pa-
tients with Corrected Transposition of the Great Arteries
with ventricular septal defect is the anomaly of the conduc-
tion tissue, which puts it at higher risk of damage during
surgical repair. Dr de Leval, in association with Dr Robert
Anderson, defined the conduction tissue distribution in cor-
rected transposition and developed a technique for placing
sutures to close the ventricular septal defect to avoid the
very high incidence of complete heart block that had been
previously seen with repair of this congenital heart
condition.
Dr de Leval has been instrumental in developing a greater
understanding of the Fontan circulation in single ventricle,
and his extensive studies with the use of computational fluid
dynamics and in vitro modeling of surgically reconstructed
Fontan circulations led to the development of the total cav-
opulmonary connection (TCPC), which showed significant
advantages over the previously standardized atriopulmo-
nary Fontan connection, improving flow characteristics
through the right side of the circulation and introducing
the concept of laminar flow and reduction of power loss
in the venous circulation that is critical for the long-term
success of the Fontan circulation. Evolution of the TCPC
principle lead others to the introduction of the extra-
cardiac Fontan connection, and Dr de Leval’s further studies
of the extra-cardiac Fontan reinforced the importance of
laminar flow and reduction in power loss in the circulation.
The introduction of the concept of total cavopulmonary
connection was a major advance in the field of single ven-
tricle surgery.
Dr de Leval has continued his interest in mathematical
modeling in surgical circulations. He has produced many
contributions to the field of flow characteristics in single
ventricle circuits by using computational fluid dynamics
and finite element analysis. His analysis of the stages of re-
construction for hypoplastic left heart syndrome has led to
an increased understanding of the circulatory characteris-
tics in this complex congenital condition.
In addition to Professor de Leval’s scientific contribu-
tions, he has also been one of the true pioneers in patient
safety and risk management research. In the early 1980s,
he became interested in the impact of human factors on sur-
gical outcomes and undertook a series of studies looking atrdiovascular Surgery c Volume 143, Number 4 767
Scientific Achievement Award Spraythe human factors and errors in organizational accidents,
which result in suboptimal outcomes in complex technol-
ogy such as congenital cardiothoracic surgery. His earliest
contributions looked at the role of human factors in pediat-
ric cardiac surgery by using the arterial switch operation as
a model. He was able to get all of the cardiac centers in the
United Kingdom to participate in a study, which highlighted
not only the importance of recovery from major errors and
failures but also the importance of minor deficiencies that
can have an additive impact, resulting in a poor outcome.
In additional to this pioneering work on human factors, he
also identified the very significant impact of communication
among caregivers on the care of the patient after cardiotho-
racic surgery. He initiated an analysis of the role of human
factors in handovers on outcomes at Great Ormond Street
Hospital and, using comparison with other high-
technology, high-performance industries such as the avia-
tion industry and the Formula One racing car industry,
showed very clearly that human factors and communication
lapses have multi-factorial effects on outcome and that im-
plementing changes, including multi-disciplinary briefing
and debriefing sessions before and after surgery and the
use of checklists in the operating room have a significant
impact on improving overall outcome. These areas of Dr
de Leval’s interests have now become extremely well768 The Journal of Thoracic and Cardiovascular Surgrecognized and many other researchers are continuing his
pioneering work in this area.
Professor de Leval is known among his many admirers
internationally as a surgeon of extraordinary intellect and
an exceptionally introspective and critical thinker. His Hon-
ored Guest address at the 82nd Meeting of the American
Association for Thoracic Surgery in Washington, DC, was
an excellent summary of the issue of medical errors and
the need to create systems to prevent the accumulation of
minor errors and that can result in a poor surgical outcome.
Marc de Leval has been a true pioneer in the field of con-
genital cardiovascular surgery. He has contributed over 330
peer-reviewed publications to the literature on a wide range
of topics in cardiac surgery and is the editor of one of the
most popular and widely used textbooks of congenital car-
diac surgery, now in its 3rd edition. He has been a mentor
and teacher to a large number of the most prominent con-
genital cardiothoracic surgeons worldwide. He retired
from active clinical practice in 2010. It was with a great
deal of pride that the American Association for Thoracic
Surgery awarded the Scientific Achievement Award of the
AATS for 2011 to Marc Roger de Leval, MD, for a distin-
guished career of research contributions in multiple areas
that have profoundly benefited the specialty of congenital
cardiothoracic surgery.ery c April 2012
